Aurora Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Sell
220
-75
-25% -$76.6K 0.17% 140
2026
Q1
$311K Hold
295
0.22% 113
2025
Q4
$317K Buy
+295
New +$282K 0.21% 112
2025
Q2
$344K Sell
442
-115
-21% -$89.4K 0.25% 101
2025
Q1
$460K Sell
557
-83
-13% -$69.1K 0.37% 72
2024
Q4
$494K Sell
640
-214
-25% -$177K 0.37% 71
2024
Q3
$757K Buy
854
+44
+5% +$39.6K 0.59% 48
2024
Q2
$733K Sell
810
-382
-32% -$306K 0.64% 43
2024
Q1
$907K Buy
1,192
+62
+5% +$44.1K 0.78% 35
2023
Q4
$659K Buy
1,130
+237
+27% +$138K 0.62% 43
2023
Q3
$479K Buy
893
+174
+24% +$89.7K 0.53% 54
2023
Q2
$337K Sell
719
-34
-5% -$14.3K 0.38% 77
2023
Q1
$259K Buy
753
+23
+3% +$7.76K 0.28% 114
2022
Q4
$267K Buy
730
+27
+4% +$9.57K 0.31% 104
2022
Q3
$227K Buy
703
+2
+0.3% +$634 0.11% 141
2022
Q2
$227K Buy
701
+2
+0.3% +$600 0.1% 151
2022
Q1
$200K Buy
+699
New +$180K 0.08% 186
2020
Q2
Sell
-1,705
Closed -$236K 208
2020
Q1
$236K Buy
+1,705
New +$234K 0.08% 194

Other funds holding LLY

Aurora Private Wealth's LLY Position: Q2 2026 in Review

Aurora Private Wealth reduced its Eli Lilly (LLY) stake by 25% in Q2 2026, selling an estimated $76.6K and leaving 220 shares worth $263K. The position accounts for 0.17% of the portfolio, ranked #140.

Aurora Private Wealth first reported a position in LLY in Q1 2020 and has held it in 18 quarters since. The position peaked at $907K in Q1 2024. 1,757 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aurora Private Wealth held 220 shares of Eli Lilly worth $263K as of Q2 2026.
  • Aurora Private Wealth sold 75 Eli Lilly shares in Q2 2026, an estimated $76.6K.
  • Eli Lilly made up 0.17% of Aurora Private Wealth's portfolio in Q2 2026, its #140 holding.
  • Aurora Private Wealth first reported a position in Eli Lilly in Q1 2020 and has held it in 18 quarters since.
  • Aurora Private Wealth's Eli Lilly position peaked at $907K in Q1 2024.
  • 1,757 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aurora Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.